Samsung Pharm Applies for Conditional Approval of PSP Treatment GV1001
Samsung Pharm announced on January 20 that it has applied to the Ministry of Food and Drug Safety for conditional approval of "GV1001," a treatment for progressive supranuclear palsy (PSP).
The application for conditional approval targets the progressive supranuclear palsy Richardson syndrome (PSP-RS) subtype as its indication. If conditional approval is granted, the company will be required to conduct clinical trials in accordance with the conditions set by the Ministry of Food and Drug Safety. In December of last year, Samsung Pharm secured the rights for clinical development and commercialization of the PSP treatment GV1001 in four major Asian countries, including Korea, through a technology transfer agreement with GemVax & KAEL.
Conditional approval is a system that allows the early market release of treatments for life-threatening cancers, other serious diseases, or rare diseases based on the results of Phase 2 clinical trials, on the condition that the results of Phase 3 clinical trials are submitted after launch.
The PSP treatment GV1001 was designated as an orphan drug in development by the Ministry of Food and Drug Safety in 2024. Samsung Pharm plans to ensure that the drug can be supplied quickly to medical sites if conditional approval is obtained.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.